Sat.Feb 22, 2025 - Fri.Feb 28, 2025

article thumbnail

The Current, Future Roles of AI within the Pharmacy Profession

Drug Topics

As artificial intelligence evolves from a novel technology to commonplace in health care, the pharmacy industry is adapting to its challenges and opportunities.

article thumbnail

What happens if you miss a dose of blood thinner?

The Checkup by Singlecare

Blood thinners are prescription drugs that keep your blood from thickening or clumping, preventing potentially life-threatening blood clots. They include anticoagulant and antiplatelet medications like heparins , Coumadin ( warfarin ), and aspirin , as well as newer-generation anticoagulants like Eliquis (apixaban) and Xarelto (rivaroxaban). Although they dont actually make your blood thinner, these medications reduce your bodys normal blood clotting response to prevent existing blood clots from

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Could novel 3D printing method enhance intestinal drug delivery?

European Pharmaceutical Review

A study has demonstrated a new approach to prepare tablets for intestinal drug delivery by combining two 3D printing techniques. Using both selective laser sintering (SLS) and fused deposition modelling (FDM), the technique has potential to achieve delayed and prolonged drug release, according to the findings. Key findings from the 3D printing drug delivery study [a] laser speed of 90 mm s1 was suitable for producing [3D printed tablet] cores with relatively short disintegration time and suffici

article thumbnail

Maximizing Impact Through Specialty Medication Therapy Management

PharmD Live

As specialty medications revolutionize treatment for chronic and complex conditions, their rising costs and intricate management requirements place a significant strain on patients, payers and providers. Without structured oversight, adherence issues, adverse drug interactions and financial barriers can lead to poor outcomes and unnecessary healthcare costs.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Covid, inflation, and Supreme Court blamed for steep drop in Native American medical school enrollment

STAT

The tiny number of Indigenous students in U.S. medical schools has long been a concern, but Native American medical leaders were taken aback to see 22% fewer American Indian or Alaska Native students had enrolled last year when numbers were released in January. “It’s pathetic, isn’t it? It’s so small,” said Donald Warne, a Lakota physician and co-director of the Center for Indigenous Health at the Johns Hopkins Bloomberg School of Public Health, as he looked cl

article thumbnail

How long does it take Linzess to work?

The Checkup by Singlecare

Linzess (linaclotide) is a brand-name medication that has long been FDA approved to treat chronic constipation from irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). In 2023, the FDA also approved Linzess as the first treatment for pediatric functional constipation, a condition in children and adolescents that causes infrequent bowel movements and hard stools that are difficult to pass.

More Trending

article thumbnail

Top 5 Fluoroquinolone Drug Interactions

Med Ed 101

Fluoroquinolones are broad-spectrum antibiotics used to treat a wide variety of bacterial infections. However, they have a long list of medication interactions that require careful consideration when prescribing and counseling. In this blog post, I will highlight my top 5 fluoroquinolone drug interactions that will likely appear in your practice or on your board exams. […] The post Top 5 Fluoroquinolone Drug Interactions appeared first on Med Ed 101.

article thumbnail

Opinion: What academic research could learn from college athletics

STAT

Since the end of World War II, the business plan of American universities has included two key principles that now are undergoing rapid disruptive change: Student-athletes participate in college sports in exchange for tuition, room, and board. Federal funding for academic research is the primary engine for the nation’s basic science enterprise.

article thumbnail

Prioritizing Access to Care and Health Equity at PQA

PQA

PQA is dedicated to improving safe, effective and appropriate medication use and addressing issues that impact a persons ability to access and use medications. As we work to address health equity and social determinants of health that affect medication use quality and patient outcomes, we believe that a diverse, equitable and inclusive workforce will strengthen PQAs efforts.

article thumbnail

Imaging discovery could accelerate drug development

European Pharmaceutical Review

Researchers at Pohang University of Science and Technology (POSTECH), South Korea, have developed a super-photostable organic dye. The discovery sets a new benchmark for organic fluorophores, Professor Young-Tae Chang explained, providing potential applications in broad areas such as drug development and cellular imaging. Single-molecule imaging uses fluorescent markers to track proteins with precision.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

When is the best time to take Prempro?

The Checkup by Singlecare

Prempro is a commonly prescribed hormone replacement therapy medication that helps decrease perimenopause or menopause symptoms. If you are experiencing hot flashes, night sweats, vaginal dryness, mood swings, or even osteoporosis , Prempro can help. You can take this medication at any time of day. However, experts agree that consistency is key. Should I take Prempro in the morning or at night?

article thumbnail

Trump administration takes aim at bird flu. For now, the cattle will have to wait

STAT

The U.S. Department of Agriculture announced Wednesday an additional $1 billion to help the nation’s poultry industry combat an accelerating outbreak of H5N1 avian influenza , which has devastated farmers and driven the price of eggs to record highs.  The infusion is part of a new strategy under the Trump administration that aims to boost financial relief to farmers whose flocks have been affected by the bird flu and aid in increasing biosecurity measures to prevent the spread from w

article thumbnail

Pharma Digital Marketing: Strategies to Boost Engagement and Drive ROI for Pharma Brands

Pharma Marketing Network

Introduction In todays fast-paced world, pharma digital marketing is more than just a strategyit’s a necessity. With increasing competition, strict regulations, and changing consumer behavior, pharmaceutical brands must embrace digital transformation to stay relevant. But how can pharma marketers break through the noise, engage their audience, and see real ROI?

article thumbnail

In Uncertain Times, Good Compliance and Quality Communication Habits Can Offer a Port in the Storm

The FDA Law Blog

By John W.M. Claud The ongoing DOGE-led reductions to the federal workforce and recent sweeping policy changes have spawned many questions for compliance officers and quality managers in FDA-regulated companies. How will the cuts at FDA impact inspections and enforcement? Will there be a heightened appetite for mergers and acquisitions in the space?

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

NICE recommends novel immunotherapy for leukaemia

European Pharmaceutical Review

The UKs National Institute For Health And Care Excellence (NICE) has recommended an innovative combination immunotherapy for use on the NHS. The therapy is indicated for individuals with the blood cancer called acute lymphoblastic leukaemia (ALL). As a bispecific T-cell engager (BiTE) therapy, Blincyto (blinatumomab) provides a new treatment approach, helping the immune system to recognise and eliminate residual cancer cells following initial treatment.

article thumbnail

Opinion: ‘Ultra-processed food’ is too broad a term to be useful

STAT

In recent years, an idea has taken hold across the ideological spectrum: The rise in diabetes and obesity in the United States is attributable to addictive, ultra-processed foods that dominate the American diet. But many people who are enthusiastically objecting to ultra-processed foods have little (if any) understanding of what the phrase means.  Legislatures, governors, government agencies, and plaintiff attorneys are taking action against ultra-processed foods, but there is no clear defi

article thumbnail

Significant Gaps Identified in Access to OTC Naloxone, Nonprescription Syringes

Drug Topics

Researchers conducted a cross-sectional study to investigate the accessibility of over-the-counter naloxone and nonprescription syringes at community pharmacies.

article thumbnail

ACI’s 43rd FDA Boot Camp – New York City Edition

The FDA Law Blog

The American Conference Institutes popular FDA Boot Camp now in its 43rd iteration is scheduled to take place from March 19-20, 2025, at the NY Bar Association in New York, NY. The conference is billed as the premier event to provide folks with a roadmap to navigate the difficult terrain of FDA regulatory law. And it is exactly that! The conference equips legal professionals without prior regulatory experience, as well as life sciences executives involved with FDA-regulated products, with a

FDA
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Preparing for a new era in the rare disease sector

European Pharmaceutical Review

Rare disease research has surged over the past decade. When observing literature trends over the past twenty years, the amount of rare disease literature being published each year has more than tripled ( Figure 1 ). 1 Following the current trend, there has been a significant rise in the number of documents mentioning both artificial intelligence (AI) and rare diseases.

article thumbnail

On measles outbreak, the Trump administration’s messaging strikes some as off-key

STAT

In 2019, amid a measles outbreak in New York, federal health officials uniformly preached the power of immunizations.  “Measles is preventable and the way to end this outbreak is to ensure that all children and adults who can get vaccinated, do get vaccinated,” said Robert Redfield , then the director of the Centers for Disease Control and Prevention.

article thumbnail

FDA Approves First Non-Hormonal Copper IUD in Over 40 Years

Drug Topics

Miudella achieves similar efficacy to other available copper IUDs with less than half the dose of copper.

FDA
article thumbnail

The ICH E6(R3) Guideline: A Major Update to Good Clinical Practice

The FDA Law Blog

By Julie Kim & Deborah L. Livornese As anticipated, the International Council for Harmonization (ICH) published the Good Clinical Practice (GCP) guideline E6(R3) Principles and Annex 1 on January 6, 2025. While ICH E6(R3) was still in the development phase, the FDA released a draft guidance in May 2023 in the form of the draft ICH E6(R3). No word yet on whether FDA will issue guidance endorsing the final ICH E6(R3).

article thumbnail

Kennedy’s MAHA agenda is tackling ‘conflicts of interest’ — and could take aim at FDA adcomms

PharmaVoice

Health agency job cuts and a newly-established MAHA commission leave many unanswered questions about potential reforms and impact on drug approvals.

FDA
article thumbnail

STAT+: New kids on the block: A new generation of VCs ventures into biotech

STAT

Biotech venture capital is on the precipice of a generational shift. At least, that’s according to the crowd of younger firm founders edging their way in. There’s long been a small batch of scientists and business leaders who invest in drug companies. For the first 15 years of the 21st century, you’d find only 400, maybe 450 VC firms regularly giving money to drug startups — biotech’s own version of The Four Hundred , with lab coats or branded polar fleece, rat

article thumbnail

USDA Outlines Plan to Stop Bird Flu Outbreak, Lower Egg Prices

Drug Topics

US Secretary of Agriculture Brooke Rollins detailed her organizations plans to combat the bird flu and quell the concerns of rising grocery store costs.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Republican holdouts, who stated repeatedly they would not vote for the bill, ultimately opted to advance legislation which will require significant Medicaid cuts.

article thumbnail

AI deals are surging, and Recursion’s ongoing Exscientia merger points to a new world of integration

PharmaVoice

Recursion CFO Ben Taylor discusses the state of AI M&A and what companies should look for as the industry moves to new data technologies and systems.

article thumbnail

A TikTok video spurs alarm about Medicare coverage for telehealth

STAT

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Last Thursday, Rep. Ro Khanna (D-Calif.) posted a video on TikTok informing his 400,000 followers of “breaking news” that “the Trump administration announced that Medicare will stop covering telehealth on April 1st,” and calling for opposition to

article thumbnail

Poor Glycemic Control for Patients With Type 2 Diabetes Increases Risk of Long COVID Symptoms

Drug Topics

The increased risk of symptoms only includes respiratory-related symptoms or brain fog.

article thumbnail

Lifileucel Approval Paves the Way for Personalized Minimally-Invasive T-Cell Therapies

Pharmacy Times

The FDAs accelerated approval of lifileucel (Amtagvi; Iovance Biotherapeutics) marks a major milestone in immunotherapy for metastatic melanoma, building on decades of research in tumor-infiltrating lymphocyte therapy.

article thumbnail

Teva targets schizophrenia to build on innovative medicines growth

PharmaVoice

The company is leaning on its subcutaneous technology to deliver long-acting options that could prevent patients from cycling through drugs.

article thumbnail

STAT+: Pharmalittle: We’re reading about Zepbound price and dose changes, compounders suing FDA, and more

STAT

Rise and shine, everyone, another busy day is on the way. We can tell by the speed at which the notes are arriving through the various communications channels on our laptop and phone, and by the number of motor vehicles passing by our window. As for us, we are trying to slow things down by engaging in the usual ritual of brewing cups of stimulation.

article thumbnail

Seasonal Influenza Activity Begins to Decrease, But Remains Elevated Nationally

Drug Topics

With the disease burden remaining high, CVS Health announces new flu testing and treatment capabilities at approximately 1600 locations in selected states.